Literature DB >> 18485890

Regulation of brain endothelial cells migration and angiogenesis by P-glycoprotein/caveolin-1 interaction.

Stéphane Barakat1, Sandra Turcotte, Michel Demeule, Marie-Paule Lachambre, Anthony Régina, Loris G Baggetto, Richard Béliveau.   

Abstract

We have investigated the involvement of P-glycoprotein (P-gp)/caveolin-1 interaction in the regulation of brain endothelial cells (EC) migration and tubulogenesis. P-gp overexpression in MDCK-MDR cells was correlated with enhanced cell migration whereas treatment with P-gp inhibitors CsA or PSC833 reduced it. Transfection of RBE4 rat brain endothelial cells with mutated versions of MDR1, in the caveolin-1 interaction motif, decreased the interaction between P-gp and caveolin-1, enhanced P-gp transport activity and cell migration. Moreover, down-regulation of caveolin-1 in RBE4 cells by siRNA against caveolin-1 stimulated cell migration. Interestingly, the inhibition of P-gp/caveolin-1 interaction increased also EC tubulogenesis. Furthermore, decrease of P-gp expression by siRNA inhibited EC tubulogenesis. These data indicate that the level of P-gp/caveolin-1 interaction can modulate brain endothelial angiogenesis and P-gp dependent cell migration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18485890     DOI: 10.1016/j.bbrc.2008.05.012

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  P-glycoprotein trafficking at the blood-brain barrier altered by peripheral inflammatory hyperalgesia.

Authors:  Gwen McCaffrey; William D Staatz; Lucy Sanchez-Covarrubias; Jessica D Finch; Kristen Demarco; Mei-Li Laracuente; Patrick T Ronaldson; Thomas P Davis
Journal:  J Neurochem       Date:  2012-07-10       Impact factor: 5.372

2.  Knockdown of caveolin-1 decreases activity of breast cancer resistance protein (BCRP/ABCG2) and increases chemotherapeutic sensitivity.

Authors:  Melanie Herzog; Caroline Henrike Storch; Philipp Gut; Dimitry Kotlyar; Joachim Füllekrug; Robert Ehehalt; Walter Emil Haefeli; Johanna Weiss
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-10-10       Impact factor: 3.000

Review 3.  Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier.

Authors:  David S Miller
Journal:  Trends Pharmacol Sci       Date:  2010-04-24       Impact factor: 14.819

4.  The protective effects of hyperoside on Ang II-mediated apoptosis of bEnd.3 cells and injury of blood-brain barrier model in vitro.

Authors:  Yu Yan Xie; Yun Wei Lu; Gu Ran Yu
Journal:  BMC Complement Med Ther       Date:  2022-06-13

5.  The Protection of Zinc against Acute Cadmium Exposure: A Morphological and Molecular Study on a BBB In Vitro Model.

Authors:  Jacopo J V Branca; Donatello Carrino; Ferdinando Paternostro; Gabriele Morucci; Claudia Fiorillo; Claudio Nicoletti; Massimo Gulisano; Carla Ghelardini; Lorenzo Di Cesare Mannelli; Matteo Becatti; Alessandra Pacini
Journal:  Cells       Date:  2022-05-15       Impact factor: 7.666

6.  ABC transporters in cancer: more than just drug efflux pumps.

Authors:  Jamie I Fletcher; Michelle Haber; Michelle J Henderson; Murray D Norris
Journal:  Nat Rev Cancer       Date:  2010-01-15       Impact factor: 60.716

Review 7.  Physiology and pathophysiology of the blood-brain barrier: P-glycoprotein and occludin trafficking as therapeutic targets to optimize central nervous system drug delivery.

Authors:  Gwen McCaffrey; Thomas P Davis
Journal:  J Investig Med       Date:  2012-12       Impact factor: 2.895

8.  Expression and clinical significance of multidrug resistance proteins in brain tumors.

Authors:  Zhenhua Guo; Jin Zhu; Lihua Zhao; Qing Luo; Xianqing Jin
Journal:  J Exp Clin Cancer Res       Date:  2010-09-05

9.  Evidence for P-Glycoprotein Involvement in Cell Volume Regulation Using Coulter Sizing in Flow Cytometry.

Authors:  Jennifer Pasquier; Damien Rioult; Nadine Abu-Kaoud; Jessica Hoarau-Véchot; Matthieu Marin; Frank Le Foll
Journal:  Int J Mol Sci       Date:  2015-06-24       Impact factor: 5.923

10.  Cbl-b inhibits P-gp transporter function by preventing its translocation into caveolae in multiple drug-resistant gastric and breast cancers.

Authors:  Ye Zhang; Xiujuan Qu; Yuee Teng; Zhi Li; Ling Xu; Jing Liu; Yanju Ma; Yibo Fan; Ce Li; Shizhou Liu; Zhenning Wang; Xuejun Hu; Jingdong Zhang; Yunpeng Liu
Journal:  Oncotarget       Date:  2015-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.